Ganni Saif, Handing Greta, Anand Adrish, Barrett Spencer, Galvan Nhu Thao Nguyen, O'Mahony Christine, Goss John A, Cotton Ronald T, Rana Abbas
Division of Abdominal Transplant, Department of Surgery, Michael E DeBakey, Houston, TX.
Department of Student Affairs, Baylor College of Medicine, Houston, TX.
Transplant Direct. 2023 Mar 29;9(4):e1467. doi: 10.1097/TXD.0000000000001467. eCollection 2023 Apr.
Donation after circulatory death (DCD) allografts might represent one of the largest untapped sources of liver allografts. Our aim was to identify independent recipient risk factors that predict mortality in DCD allograft recipients to preselect optimal candidates for successful transplantation. Furthermore, we compared the application of our newly constructed DCD Recipient Selector Index (RSI) score to previously developed models to determine superiority in predicting recipient survival.
Using the Organ Procurement and Transplantation Network database, we performed univariate and multivariate retrospective analyses on 4228 DCD liver allograft recipients.
We identified 8 significant factors and incorporated them into the weighted RSI to predict 3-mo survival following DCD liver transplantation with a C-statistic of 0.6971. The most significant recipient risk factors were recipient serum sodium levels >150 mEq/L at transplant, recipient albumin <2.0 g/dL at transplant, and a history of portal vein thrombosis. Because Model for End-Stage Liver Disease (MELD) score components were included as individual predictors, the DCD RSI predicts survival independently of MELD. Upon comparison with 3 previous recipient risk scores-Balance of Risk, Renal Risk Index, Patient-Survival Outcomes Following Liver Transplantation-the DCD RSI was determined to be superior at selecting optimal candidates pre-DCD transplantation, yielding a C-statistic of 0.6971.
After verifying the performance of predictive indices for selection of DCD recipients, the DCD RSI is best used to preselect patients for optimized outcomes after DCD transplantation. This can increase utilization of DCD donors by improving outcomes.
心脏死亡后捐赠(DCD)的同种异体移植物可能是最大的未开发肝脏同种异体移植物来源之一。我们的目的是确定预测DCD同种异体移植受者死亡率的独立受者风险因素,以便预先选择成功移植的最佳候选者。此外,我们将新构建的DCD受者选择指数(RSI)评分的应用与先前开发的模型进行比较,以确定在预测受者生存方面的优越性。
使用器官获取与移植网络数据库,我们对4228例DCD肝脏同种异体移植受者进行了单变量和多变量回顾性分析。
我们确定了8个显著因素,并将其纳入加权RSI中,以预测DCD肝移植后3个月的生存率,C统计量为0.6971。最显著的受者风险因素是移植时受者血清钠水平>150 mEq/L、移植时受者白蛋白<2.0 g/dL以及门静脉血栓形成史。由于终末期肝病模型(MELD)评分成分被作为单独的预测因素,DCD RSI独立于MELD预测生存率。与之前的3个受者风险评分——风险平衡、肾风险指数、肝移植后患者生存结果——进行比较后,确定DCD RSI在DCD移植前选择最佳候选者方面更具优势,C统计量为0.6971。
在验证了DCD受者选择预测指标的性能后,DCD RSI最适合用于预先选择患者,以实现DCD移植后的优化结果。这可以通过改善结果来提高DCD供体的利用率。